ISOLYSER CO INC /GA/
10-Q, 1998-05-14
ORTHOPEDIC, PROSTHETIC & SURGICAL APPLIANCES & SUPPLIES
Previous: TEL COM WIRELESS CABLE TV CORP, 10QSB/A, 1998-05-14
Next: SECURFONE AMERICA INC, NT 10-Q, 1998-05-14



                       SECURITIES AND EXCHANGE COMMISSION
                             WASHINGTON, D.C. 20549
                                    FORM 10-Q

                QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15 (D)
                     OF THE SECURITIES EXCHANGE ACT OF 1934


For Quarter Ended          March 31, 1998           Commission File No.  0-24866
                           --------------                                -------


                             ISOLYSER COMPANY, INC.
             (Exact name of Registrant as specified in its charter)


   Georgia                                                58-1746149
(State or other jurisdiction of                        (IRS Employer
 incorporation or organization)                      Identification No.)

                              650 Engineering Drive
                                 Technology Park
                             Norcross, Georgia 30092
                    (Address of principal executive offices)

                                 (770) 582-6363
              (Registrant's telephone number, including area code)

Indicate by check mark whether the registrant (1) has filed all reports required
to be filed  by  Section  13 or 15 (d) of the  Securities  Exchange  Act of 1934
during the preceding 12 months (or for such shorter  period that the  registrant
was  required  to file such  reports),  and (2) has been  subject to such filing
requirements for at least the past 90 days.

Yes   X     No
    -----      -----

Indicate the number of shares  outstanding  of each of the  issuer's  classes of
common equity, as of the latest practicable date.

Class                                             Outstanding at May 12, 1998
- -----                                             ---------------------------
Common Stock, $.001 par value                             39,958,300


547812.2

<PAGE>

                                     PART I
                              FINANCIAL INFORMATION

ITEM 1. FINANCIAL STATEMENTS

                             ISOLYSER COMPANY, INC.
                      Condensed Consolidated Balance Sheets
                                 (in thousands)
                                   (unaudited)

<TABLE>
<CAPTION>
                                 ASSETS                               MARCH 31, 1998        DECEMBER 31, 1997
                                 ------                              ---------------------------------------- 
<S>                                                                    <C>                  <C>               
Current Assets
        Cash and cash equivalents                                      $    9,813           $    9,299
        Accounts receivable, net                                           15,430               13,909
        Inventories                                                        30,091               32,067
        Prepaid expenses and other assets                                   1,588                1,745
        Assets held for sale                                               35,081               35,751
                                                                        ---------            --------- 
                 Total Current Assets                                      92,003               92,771
                                                                        ---------            ---------
Property, plant and equipment                                              39,115               37,622
        Less accumulated depreciation                                    (18,260)             (17,630)
                                                                        ---------            ---------
                 Property, plant, and equipment, net                       20,855               19,992
Intangibles and other assets, net                                          31,124               31,571
                                                                        ---------            ---------
                                                                       $  143,982           $  144,334
                                                                        =========            =========
                  LIABILITIES AND SHAREHOLDERS' EQUITY
Current liabilities
        Current installments of long term debt                         $    3,647           $    4,610
        Accounts payable                                                    7,793               10,108
        Bank overdraft                                                        483                    -
        Accrued expenses                                                    4,861                5,644
                                                                        ---------            ---------
                 Total current liabilities                                 16,784               20,362
                                                                        ---------            ---------
Long term debt, excluding current installments                             41,705               37,546
        Other liabilities                                                     286                  309
                                                                        ---------            ---------
                 Total liabilities                                         58,775               58,217
                                                                        ---------            ---------
Shareholders' equity
        Common stock                                                           39                   39
        Additional paid in capital                                        203,017              203,601
        Retained earnings                                               (117,031)            (115,743)
        Cumulative translation adjustment                                   (102)                (103)
        Unearned shares restricted to employee stock ownership plan         (300)                (300)
                                                                        ---------            ---------
                                                                           85,623               87,494
Treasury shares                                                             (416)              (1,377)
                                                                        ---------            ---------
        Total shareholders' equity                                         85,207               86,117
                                                                        ---------            ---------
                                                                       $  143,982           $  144,334
                                                                        =========            =========

See accompanying notes.
</TABLE>

547812.2
                                       -2-

<PAGE>



                             ISOLYSER COMPANY, INC.
                 Condensed Consolidated Statement of Operations
                      (in thousands, except per share data)
                                   (unaudited)
<TABLE>
<CAPTION>

                                                                THREE MONTHS ENDED     THREE MONTHS ENDED
                                                                  MARCH 31, 1998         MARCH 31, 1997
                                                                ------------------------------------------
<S>                                                             <C>                      <C>
Net sales                                                       $   41,230               $   40,003
Costs of goods sold                                                 30,588                   30,846
                                                                ----------                ---------
          Gross profit                                              10,642                    9,157
Operating expenses:
          Selling & marketing                                        6,122                    6,902
          General & administrative                                   3,668                    3,632
          Research & development                                       681                      768
          Amortization of intangibles                                  527                      956
                                                                ----------                 --------   
                   Total operating expenses                         10,998                   12,258
                                                                ----------                 ---------
Loss from operations                                                 (356)                  (3,101)
Interest income                                                         92                      228
Interest expense                                                     (950)                  (1,020)
Gain (loss) in joint venture                                             3                     (13)
                                                                ----------                 ---------
Loss before income tax expense                                     (1,211)                  (3,906)
Income tax expense                                                      76                        4
                                                                ----------                 ---------
Net loss                                                        $  (1,287)                $ (3,910)
                                                                ----------                 ---------
Net loss per common share - Basic and Diluted                   $   (0.03)                $  (0.10)
                                                                ==========                 =========
Weighted average number of common shares outstanding                39,512                   38,828
                                                                ==========                 =========

See accompanying notes.
</TABLE>


547812.2
                                       -3-

<PAGE>



                             ISOLYSER COMPANY, INC.
                        Condensed Statement of Cash Flows
                                 (in thousands)
                                   (unaudited)
<TABLE>
<CAPTION>

                                                                 THREE MONTHS ENDED    THREE MONTHS ENDED
                                                                   MARCH 31, 1998        MARCH 31, 1997
                                                                 ----------------------------------------
<S>                                                              <C>                     <C>
Cash flows from operating activities:
          Net loss                                                $ (1,287)              $  (3,910)
Adjustments to reconcile net loss to net cash used in operating
activities:
          Depreciation                                                  965                   1,834
          Amortization                                                  527                     956
          Provision for doubtful accounts                                66                      57
          Loss on disposal of property, plant & equipment                10                       6
          Changes in assets and liabilities                         (1,956)                 (2,500)
                                                                   --------               ---------
NET CASH USED IN OPERATING ACTIVITIES:                              (1,675)                 (3,557)
                                                                   --------               ---------
Cash flows from investing activities
          Additions to property, plant and equipment                (1,651)                 (1,166)
                                                                   --------               ---------
NET CASH USED IN INVESTING ACTIVITIES:                              (1,651)                 (1,166)
                                                                   --------               ---------
Cash flows from financing activities:
          Net borrowings under credit agreements                      3,270                   2,524
          Changes in bank overdraft                                     194                 (1,459)
          Proceeds from exercised stock options                           -                     574
          Proceeds from issuance of stock                               255                     306
          Issuance of stock to 401(k) Plan                              121                       -
                                                                   --------               ---------
NET CASH PROVIDED BY FINANCING ACTIVITIES:                            3,840                   1,945
                                                                   --------               ---------
Net increase (decrease) in cash and cash equivalents                    514                 (2,778)
Cash and cash equivalents at beginning of period                      9,299                  20,925
                                                                   --------               ---------
CASH AND CASH EQUIVALENTS AT END OF PERIOD                        $   9,813              $   18,147
                                                                   ========               =========

See accompanying notes.
</TABLE>

547812.2
                                       -4-

<PAGE>



                             ISOLYSER COMPANY, INC.
                   NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
                                   (UNAUDITED)

1) In  the  opinion  of  management,  the  information  furnished  reflects  all
adjustments  (consisting only of normal recurring  adjustments)  necessary for a
fair  presentation  of the financial  position,  results of operations  and cash
flows  for  the  interim  periods.  Results  for  the  interim  periods  are not
necessarily  indicative  of results  to be  expected  for the full  year.  These
consolidated  financial  statements  should  be read  in  conjunction  with  the
consolidated  financial  statements and notes thereto contained in the Company's
Annual  Report on Form 10-K for the year ended  December  31, 1997 (the  "Annual
Report").

2)  Inventories  are stated at the lower of cost or market and are summarized as
follows:

                                            MARCH 31, 1998     DECEMBER 31, 1997
                                            --------------     -----------------
  
Raw materials and supplies                  $  23,543,000        $  24,121,000
Work in process                                 3,950,000            4,456,000
Finished goods                                 24,681,000           25,901,000
                                             ------------         ------------
         Total                                 52,174,000           54,478,000

Reserve for excess, slow moving and 
obsolete inventory                           (22,083,000)         (22,411,000)
                                             ------------         ------------
         Total                              $  30,091,000        $  32,067,000
                                             ============         ============

         At March 31,  1998 and  December  31,  1997 the net OREX  inventory  is
approximately $6,326,000 and $7,500,000 respectively.

3) On February  25,  1998,  the  Company  approved a plan to dispose of its OREX
manufacturing  facilities  and White  Knight  subsidiary.  Accordingly,  the net
assets of these  entities at March 31, 1998 and December 31, 1997 are classified
as held  for  sale in the  accompanying  consolidated  balance  sheets,  and are
comprised of the following:

                                           MARCH 31, 1998    DECEMBER 31, 1997
                                           --------------    -----------------
Assets:
     Accounts receivable                   $ 9,348,000           $ 8,848,000
     Inventory                              11,942,000            13,085,000
     Prepaid expense and other assets        1,067,000               186,000
     Property and equipment, net            19,794,000            19,980,000
     Other assets                              280,000               286,000
                                            ----------            ----------
              Total assets                 $42,431,000           $42,385,000
                                            ----------            ----------



547812.2
                                       -5-

<PAGE>




                                           MARCH 31, 1998    DECEMBER 31, 1997
                                           --------------    -----------------
Liabilities:
         Accounts payable                    $  3,317,000      $  2,247,000
         Bank overdraft                           219,000           508,000
         Accrued liability                      1,905,000         2,044,000
         Long-term debt                         1,909,000         1,836,000
                                              -----------        ----------

                  Total liabilities             7,350,000         6,635,000
                                              -----------        ----------    

                  Net assets held for sale   $ 35,081,000      $ 35,750,000
                                              ===========        ==========



The Company anticipates disposing of these entities in 1998.

The following represents the results of operations of the above noted assets and
White Knight for the quarters ended March 31, 1998 and December 31, 1997:

                                               QUARTER ENDED     QUARTER ENDED
                                               MARCH 31, 1998  DECEMBER 31, 1997
                                               --------------  -----------------
Net sales                                    $   11,592,474      $  13,357,000
Net loss                                        (1,850,927)        (1,882,000)
Net loss per share - basic and diluted               (0.05)             (0.05)
                                               ------------       ------------



4) Loss per common share is computed using the weighted average number of common
shares outstanding during the respective periods. There is no difference between
basic and diluted weighted average and per share amounts for these periods.

5) In June 1997,  the  Financial  Accounting  Standards  Board  issued SFAS 130,
"Reporting Comprehensive Income". Effective January 1, 1998, the Company adopted
SFAS 130.  Management  believes the pronouncement does not significantly  impact
the presentation of the Company's consolidated financial statements.

ITEM 2.

MANAGEMENT'S  DISCUSSION  AND  ANALYSIS OF  FINANCIAL  CONDITION  AND RESULTS OF
OPERATIONS

RESULTS OF OPERATIONS

Net sales for the three months ended March 31, 1998 ( the "1998  Quarter")  were
$41.2  million  compared to $40.0  million for the three  months ended March 31,
1997 ( the "1997 Quarter"). Sales of custom procedure trays and related products
increased  22.0% in the 1998  Quarter  as  compared  to the 1997  Quarter.  This
increase is primarily attributable to the relief of backlog

547812.2
                                       -6-

<PAGE>



created by the reduction of production  during the Company's  implementation  of
and conversion to an upgraded  manufacturing system during the fourth quarter of
1997, and new business.  Sales of Microtek  products  increased 2.8% in the 1998
Quarter as compared to the 1997  Quarter,  primarily  attributable  to increased
market  penetration at the hospital  level.  Sales of safety  products  declined
18.5% in the 1998 Quarter as compared to the 1997 Quarter,  due to a substantial
reduction in purchases of LTS products by Allegiance, the primary distributor of
such products,  and recent adverse  regulatory  developments.  While the Company
plans to  introduce a new LTS product to preserve  its market  share  created by
LTS, the Company's ability to do so is subject to obtaining federal registration
of such product. The Company expects that its operating results will continue to
be adversely affected by reduced sales of LTS, and no assurances can be provided
that the Company will be able to maintain  its market share on such  products by
the  registration  and  introduction  of a new LTS  product.  White Knight sales
declined  14.2% in the 1998  Quarter as compared to the 1997  Quarter,  due to a
competitor's  purchase of a significant  customer and the Company's  decision to
de-emphasize  marketing  of White  Knight  products  in favor of  higher  margin
products  sold  by its  other  subsidiaries.  Sterile  Concepts,  a  significant
customer of White Knight, was acquired by Maxxim,  which is a product competitor
of the Company, in 1996. While Sterile Concepts remains contractually  obligated
to purchase a yearly  minimum of $5.1  million of products  until June 30, 1998,
the Company  expects that Sterile  Concepts will no longer purchase White Knight
products.  The Company is negotiating with Maxxim for a new supply agreement for
the sale of other  products  of the  Company in  settlement  of the  outstanding
obligations of Sterile  Concepts to White Knight.  No assurances can be provided
that the Company will be able to complete any such settlement  negotiations.  In
February 1998, the Company announced plans to sell its White Knight  subsidiary,
which, if consummated,  would significantly  reduce the Company's net sales. See
"Risk Factors - Risks of Planned Divestitures" in the Company's Annual Report.

Included  in the  foregoing  sales  figures  are $1.8  million  in sales of OREX
Degradables  during the 1998  Quarter as  compared  to $2.1  million in the 1997
Quarter.  Sales of OREX  Degradables  in the 1998 Quarter did not contribute any
gross  profits to the  Company's  operating  results.  During 1997,  the Company
substantially  reduced its selling and  marketing  efforts to increase  sales of
OREX  Degradables  and  instead  focused  on  preserving  its  existing  base of
hospitals purchasing OREX Degradables and evaluating means to exploit the market
position of OREX Degradables within its various market  potentials.  The Company
to date has not achieved any gross profits on its sale of OREX Degradables.  The
Company's  future  performance  will depend to a substantial  degree upon market
acceptance of and the Company's  ability to  successfully  manufacture,  market,
deliver and expand its OREX  Degradables  line of products at acceptable  profit
margins.  The  Company's  ability to achieve such  objective is subject to risks
including  the risks  described  in the  Company's  Annual  Report  under  "Risk
Factors."

Gross  profit in the 1998  Quarter was $10.6  million,  or 25.8% of net sales as
compared to $9.2 million in the 1997 Quarter,  or 22.9% of net sales.  The 16.2%
improvement in gross profit is  attributable  to increased  gross profits at the
Company's  custom  procedure  tray and Microtek  divisions  on increased  sales,
commencing  utilization  of  manufacturing  capacity at the Company's  Abbeville
manufacturing  plant for the production of traditional  products on a short-term
basis,

547812.2
                                       -7-

<PAGE>



and reduced  depreciation expense due to impairment reserves recorded during the
fourth quarter of 1997.

Selling,  general and administrative  expenses were $9.8 million or 23.7% of net
sales in the 1998 Quarter as compared to $10.5  million or 26.3% of net sales in
the 1997 Quarter. The reduction in selling,  general and administrative  expense
is primarily  attributed to implementation of the Company's  operating plan that
focused on  reorganizing  marketing and sales  efforts to achieve  reductions in
selling and marketing expenses.

Research and  development  expenses were $681,000 in the 1998 Quarter or 1.7% of
net sales as compared to $768,000 in the 1997 Quarter or 1.9% of net sales.  The
decline in research and development expense is primarily attributed to a decline
in expenses incurred in the development of fiber technology.

Amortization  of  intangibles  was  $527,000 in the 1998  Quarter as compared to
$956,000 in the 1997  Quarter.  The decline in  amortization  expense was due to
charges  recorded  during the fourth quarter of 1997 for the impairment of White
Knight's carrying value.

The resulting loss from  operations was $356,000 in the 1998 Quarter as compared
to a $3.1 million loss from operations in the 1997 Quarter.

Interest  expense,  net of interest income,  was $858,000 in the 1998 Quarter as
compared to $792,000 in the 1997  Quarter.  The increase in interest  expense is
attributed to increases in the Company's  borrowing  interest rate combined with
lower  interest  income  as a result  of lower  cash  balances  during  the 1998
Quarter,  offset by reduced interest  expense as a result of reduced  borrowings
during 1997.

Provision  for income taxes reflect an expense of $76,000 in the 1998 Quarter as
compared to an expense of $4,000 in the 1997 Quarter.

The  resulting  net loss was $1.3  million for the 1998 Quarter as compared to a
net loss of $3.9 million for the 1997 Quarter.


LIQUIDITY AND CAPITAL RESOURCES

At March 31, 1998,  the Company's cash and  equivalents  totaled $9.8 million as
compared to $9.3 million at December 31, 1997.

During the 1998  Quarter,  the Company  used $1.7  million of cash in  operating
activities  as compared to a cash use of $3.6 million in the 1997  Quarter.  The
use of  cash  in the  1998  Quarter  is  attributable  to a  combination  of the
Company's  operating  loss,  increases in accounts  receivable as a result of an
incremental increase in sales of $5.6 million in the 1998 Quarter as compared to
the fourth quarter of 1997 and a decrease in accounts payable as a result of the
fourth quarter

547812.2
                                       -8-

<PAGE>



1997 build-up of inventory at the Company's  custom  procedure tray division due
to systems  conversion.  The Company used $1.7  million in investing  activities
during  the 1998  Quarter  as  compared  to $1.2  million  used  during the 1997
Quarter. This use of cash during the 1998 Quarter was primarily  attributable to
several computer software implementations in progress.  During the 1998 Quarter,
the  Company  generated  approximately  $3.8  million  in  cash  from  financing
activities,  primarily  through  increasing  indebtedness  under  the  Company's
revolving  line of credit,  compared to cash  provided by  financing  activities
approximating $1.9 million in the 1997 Quarter.

As more fully described in the Company's Annual Report on Form 10-K, the Company
has a $55 million credit agreement (the "Credit Agreement")  consisting of a $40
million  revolving credit facility maturing on August 31, 1999 and a $15 million
term loan facility  maturing on August 31, 2001.  Current  additional  borrowing
availability  under  the  revolving  credit  facility  at  March  31,  1998  was
approximately  $4.2 million.  Outstanding  borrowings under the revolving credit
facility  were  approximately  $28.6  million  at March  31,  1998.  Outstanding
borrowings  under the term loan  facility  were $11.8 million at March 31, 1998.
The Credit Agreement provides for the issuance of up to $3 million in letters of
credit.  Outstanding  letters of credit were $50,000 at March 31, 1998. In March
1998,  the Bank and the Company  amended the Credit  Agreement to revise certain
covenants.  While the Company does not currently anticipate that it will violate
the  covenants  of the Credit  Agreement  in the future,  no  assurances  can be
provided that these or other violations of covenants  contained in the Company's
Credit Agreement will not occur in the future or that, if such violations occur,
that the Bank will not elect to pursue its remedies under the Credit  Agreement.
Any unwaived default by the Company under the Credit Agreement would be expected
to have a  material  adverse  effect  upon  the  Company.  At  March  31,  1998,
outstanding  indebtedness under the Credit Agreement exceeded the Company's cash
and cash equivalents.

Based upon its current  business plan, the Company  currently  expects that cash
equivalents  and short term  investments on hand, the Company's  existing credit
facility and funds budgeted to be generated from  operations will be adequate to
meet its liquidity and capital  requirements  through 1998. Currently unforeseen
future  developments  and increased  working  capital  requirements  may require
additional  debt  financing or issuance of common  stock in 1998 and  subsequent
years.  There can be no  assurances  that the Company  could obtain any required
additional debt financing or successfully consummate an issuance of common stock
on terms favorable to the Company, if at all.

Statements  made in this  Management's  Discussion  and  Analysis  of  Financial
Condition  and  Results  of  Operations,  including  those  in  the  immediately
preceding  paragraph,   include  forward-  looking  statements  made  under  the
provisions of the Private Securities Litigation Reform Act. The Company's actual
results could differ  materially from such  forward-looking  statements and such
results  will be affected by risks  described  in the  Company's  Annual  Report
including,  without  limitation,  those  described under "Risk Factors - Limited
Operating History; Net Losses", "-Risks of New Products",  "Risks of Expansion",
"-Manufacturing & Supply Risks" and "Liquidity Risks".

547812.2
                                       -9-

<PAGE>




ITEM 3.

Quantitative and Qualitative Disclosures about Market Risk

Not applicable.




547812.2
                                      -10-

<PAGE>



                                     PART II

                                OTHER INFORMATION


ITEM 1.  LEGAL PROCEEDINGS

Not applicable.

ITEM 2.  CHANGES IN SECURITIES

During the  quarter  for which  this  report is filed,  there  were no  material
modifications in the instruments defining the rights of shareholders. During the
quarter  for which this  report is filed,  none of the rights  evidenced  by the
shares of the Company's common stock were materially limited or qualified by the
issuance or  modification  of any other class of securities.  During the quarter
for which this report is filed,  the Company  sold no equity  securities  of the
Company that were not registered under the Securities Act of 1933, as amended.

ITEM 3.  DEFAULTS UPON SENIOR SECURITIES

None.

ITEM 4.  SUBMISSION OF MATTERS TO A VOTE OF SECURITYHOLDERS

None.

ITEM 5.  OTHER INFORMATION

None.

ITEM 6.  EXHIBITS AND REPORTS ON FORM 8-K

(a)      Exhibits:

Exhibit No.         Description
- -----------         -----------

3.1(1)              Articles of Incorporation of Isolyser Company, Inc.

3.2(2)              Articles  of  Amendment  to  Articles  of  Incorporation  of
                    Isolyser Company, Inc.

3.3(1)              Amended and Restated Bylaws of Isolyser Company, Inc.

3.4(3)              First  Amendment to Amended and Restated  Bylaws of Isolyser
                    Company, Inc.


547812.2
                                      -11-

<PAGE>



3.5(4)              Second  Amendment to Amended and Restated Bylaws of Isolyser
                    Company, Inc.

4.1(1)              Specimen Certificate of Common Stock

10.1                Employment  Agreement  dated as of January 1, 1998,  between
                    the Company and Terence N. Furness

10.2                Employment  Agreement dated as of February 1, 1998,  between
                    the Company and Migirdic Nalbantyan

27.1                Financial Data Schedule

- ------------------


1.   Incorporated by reference to the Company's  Registration  Statement on Form
     S-1 (File No.
         33-83474).

2.   Incorporated by reference to Exhibit 3.2 of the Company's  Annual Report on
     Form 10-K for the year ended December 31, 1996.

3.   Incorporated by reference to Exhibit 3.1 to the Company's Current Report on
     Form 8-K filed July 29, 1996.

4.   Incorporated by reference to Exhibit 3.1 to the Company's Current Report on
     Form 8-K filed December 20, 1996.

     (b) No current  reports on Form 8-K were filed during the quarter for which
this report is filed.



547812.2
                                      -12-

<PAGE>


                                   SIGNATURES


Pursuant  to the  requirements  of the  Securities  Exchange  Act of  1934,  the
registrant  has caused  this  quarterly  report on Form 10-Q to be signed on its
behalf by the undersigned thereunto duly authorized on May 13, 1998.


                                    ISOLYSER COMPANY, INC.



                                          By:/s/ Terence N. Furness
                                             ---------------------------------
                                              Terence N. Furness
                                              President & CEO
                                              (principal executive officer)


                                          By:/s/ Peter A. Schmitt
                                             ---------------------------------
                                              Peter A. Schmitt
                                              Chief Financial Officer
                                              (principal financial officer)






547812.2
                                      -13-





                              EMPLOYMENT AGREEMENT

         THIS AGREEMENT ("Agreement") is made and entered into on the 1st day of
January,  1998 but effective as of the 1st day of January,  1998 (the "Effective
Date"),   by  and  between  ISOLYSER  COMPANY,   INC.,  a  Georgia   corporation
(hereinafter   the  "Company"),   and  TERENCE  N.  FURNESS   (hereinafter   the
"Employee").

                                    RECITALS:

         R-1.  The  Company  develops,   manufactures  and  markets  disposable,
specialty  and safety  products for use in medical,  industrial  and  commercial
markets.

         R-2.     The Company's markets are worldwide.

         R-3.  The Company  maintains  certain  trade  secrets and  confidential
information which is proprietary to the Company,  the disclosure or exploitation
of which would cause significant damage to the Company.

         R-4.  The  Company  desires to employ the  Employee,  and the  Employee
desires to accept such  employment,  for which  purposes each of the Company and
the  Employee  desire to enter  into  this  Agreement  to set forth and  clarify
certain of the terms and conditions relevant to such employment.

         R-5. The Company  recognizes  that,  as is the case with many  publicly
held  corporations,  the  possibility of a Change in Control (as defined herein)
may arise which may create uncertainty and questions among management  resulting
in a departure or  distraction  of management  personnel to the detriment of the
Company and its shareholders.  In addition, the Company believes that should the
Company or its  shareholders  receive a proposal  for transfer of control of the
Company, the Employee should be able to assess and advise the Company

500450.4

<PAGE>



whether  such  proposal  would be in the best  interests  of the Company and its
shareholders  and to take such other action regarding such proposal as the Board
of Directors might determine to be appropriate  without being  influenced by the
uncertainty of the Employee's own situation.

         NOW,  THEREFORE,  in consideration  of the recitals,  the covenants and
agreements  herein  contained  and the  benefits  to be  derived  herefrom,  the
parties, intending to be legally bound, agree as follows:

         1.  Recitals.  The  recitals  set forth above  constitute  part of this
Agreement and are incorporated herein by this reference.

         2.  Employment.  From and after the date hereof and for the term herein
provided,  the Company  agrees to employ the Employee as the President and Chief
Executive Officer of the Company,  and the Employee accepts such employment with
the Company upon the terms and conditions  hereinafter  set forth.  3. Term. The
Employee's employment shall commence from and after the date hereof and, subject
to Section 8 of this  Agreement,  shall  continue  through the date  immediately
preceding  the third  anniversary  of the  Effective  Date.  Upon any  scheduled
expiration date of the Agreement,  this Agreement shall  automatically renew for
successive  periods of one year unless either party shall give written notice to
the other party of  non-renewal at least thirty (30) days prior to the scheduled
expiration date of this Agreement.  Any such notice of non-renewal  given by the
Company shall be treated as a termination  without Cause as set forth in Section
8(c) of this Agreement, and any such notice of non-renewal given by the Employee
shall be treated as a  termination  without  Good Reason as set forth in Section
8(d) of this Agreement.  4. Duties.  Subject to the direction and supervision of
the Board of Directors of the Company,  the Employee  agrees that:  (a) he shall
devote his full  working  time and  attention to the business of the Company and
its affiliated companies; (b) he will perform all of his duties

500450.4
                                        2

<PAGE>



pursuant to this  Agreement  faithfully  and to the best of his  abilities  in a
manner intended to advance the Company's interests;  and (c) he shall not engage
in any other  business  activity  except:  (i) investing  assets in a manner not
prohibited  by  Section  9(e) of this  Agreement,  and in such form or manner as
shall not require any material services on his part in the operations or affairs
of the  companies or other  entities in which such  investments  are made,  (ii)
serving on the board of directors of any company,  subject to the provisions set
forth in  Section  9(e) of this  Agreement  and  provided  that he shall  not be
required to render any  material  services  with  respect to the  operations  or
affairs of any such company,  (iii)  engaging in religious,  charitable or other
community or  non-profit  activities  which do not impair his ability to fulfill
his  duties  and  responsibilities  under  this  Agreement,  or (iv) such  other
activities as may be expressly  approved in advance by the Board of Directors of
the Company.
         5. Compensation.  As full compensation for all services rendered by the
Employee  pursuant to this  Agreement and as full  consideration  for all of the
terms of this Agreement,  the Employee shall receive from the Company during his
employment,  but only from and after the Effective Date of this  Agreement,  the
base salary, bonuses and fringe benefits described below.

                  (a) Base Salary.  For all services  rendered  pursuant to this
Agreement,  the Company  shall pay or cause to be paid to the Employee an annual
base salary of $250,000 (the "Floor Amount"). The annual salary may be increased
or (subject to the terms of this  Agreement)  decreased from time to time during
the term of this  Agreement in the  discretion  of the Company.  The base salary
shall be payable in accordance  with the customary  practices of the Company for
payment of its employees,  but in any event, in installments not less frequently
than once monthly.

                  (b) Bonus  Compensation.  The Company  shall  establish  on an
annual  basis a bonus  compensation  plan for the  benefit  of the  Employee  in
accordance with which the

500450.4
                                        3

<PAGE>



Employee  shall be eligible  for a bonus  potential  of up to at least the Floor
Amount on such terms and  conditions  as the Board of Directors  (or a committee
thereof) may set in its sole discretion.

                  (c) Long Term Incentive Payments.  The Company has or may from
time to time in the  future  grant  to the  Employee  such  long-term  incentive
compensation  (including,  by way of  illustration  but  not  limitation,  stock
options) as the Board of Directors may determine in its discretion.

                  (d) Fringe Benefits. The Company has adopted, or may from time
to time adopt,  policies in respect of fringe benefits for its management  level
employees  in the  nature  of health  and life  insurance,  holidays,  vacation,
disability and other matters. The Company covenants and agrees that the Employee
shall be entitled to participate in any such fringe benefit  policies adopted by
the Company to the same extent that such fringe  benefits  shall be available to
and for the benefit of all other management level employees.

                  (e) Tax Withholdings and Other  Deductions.  The Company shall
have the right to deduct  from the base salary and any  additional  compensation
payable to the  Employee  all amounts  required to be deducted  and  withheld in
accordance  with social  security  taxes and all applicable  federal,  state and
local  taxes and  charges  as may now be in  effect  or which  may be  hereafter
enacted or required as charges on the compensation of the Employee.  The Company
shall  also have the right to offset  from the base  salary  and any  additional
compensation  payable  to the  Employee  any loan or other  amounts  owed to the
Company by the Employee.

         6. Working Facilities.  The Company, at its own expense,  shall furnish
the Employee with office,  working space and such equipment as may be reasonably
necessary for the Employees's performance of his or her duties.

500450.4
                                        4

<PAGE>



         7.  Expenses.  The Employee is required as a condition of employment to
incur  ordinary,  necessary  and  reasonable  expenses for the  promotion of the
business of the Company and its affiliates and subsidiaries,  including expenses
for entertaining,  travel and similar items. The Employee is authorized to incur
reasonable  expenses in  connection  with such  business,  including  travel and
entertainment  expenses, fees for seminars and courses, and expenses incurred in
attendance at executive meetings and conventions.  If paid by the Employee, upon
presentation  by the Employee of an itemized  account of such  expenditures in a
manner  satisfactory  to the Company,  the Employee shall be entitled to receive
reimbursement  for these  expenses,  subject to policies that may be established
from time to time by the Company. It is intended by the Company and the Employee
that all expenses  incurred  pursuant to this  paragraph  are to be ordinary and
necessary business expenses.

         8.  Termination.   The  Employee's  employment  may  be  terminated  in
accordance  with the provisions of this Section.  The provisions for termination
are as follows:

                  (a) Death or Disability.  The Employee's  employment  shall be
terminated  upon the (i)  death of the  Employee  or (ii) the  inability  of the
Employee to perform his duties and responsibilities  hereunder in the manner and
to the extent  required by this Agreement for a period of 180  consecutive  days
due to physical or mental illness or other  condition of such character as would
entitle the Employee to benefits under the Company's long-term  disability plan.
While the Employee is so affected and prior to  termination  of this  Agreement,
the Company may  designate  an acting  President or Chief  Executive  Officer or
both.

                  (b)  Termination For Cause.  The Employee's  employment may be
terminated by the Company for Cause.  For purposes of this  Agreement,  the term
"Cause" shall mean a determination  made in good faith by the Board of Directors
that any of the following has occurred: (i) the Employee's failure or refusal to
comply with the material published policies,

500450.4
                                        5

<PAGE>



standards  and   regulations  of  the  Company  from  time  to  time  reasonably
established and fairly  administered by the Company which has a material adverse
effect or reflection upon the Company, (ii) a material breach by the Employee of
the terms of Section 9 of this Agreement,  (iii) a breach by the Employee of any
of the other  material  terms of this  Agreement,  or (iv) the conviction of the
Employee  for  any  felony  (other  than  related  to the  operation  of a motor
vehicle),  the conviction of the Employee for a misdemeanor involving the misuse
of funds, or the final  adjudication (with all periods of appeal having expired)
by a court that the Employee  engaged in willful  misconduct in connection  with
the activities of the Company.

                  (c) Termination  Without Cause. The Employee's  employment may
be terminated by the Company without Cause; provided,  that, in the event of any
termination of the Employee's  employment under this paragraph (c), the Employee
shall be  entitled to receive  (i) such  Employee's  annual base salary (but not
less than the Floor  Amount  per year) as then in effect as set forth in Section
5(a)  hereof  until the first  anniversary  of the date of such  termination  of
employment  payable  at the  Company's  election  either in a lump sum  (present
valued at a discount rate of 5%) or as otherwise payable under Section 5(a), and
(ii) the benefits set forth in Section  8(e)(ii)(C) of this Agreement subject to
and in accordance  with the terms and provisions of such section.  The Company's
obligation to make payments  under this  paragraph  shall cease and terminate in
the event of any breach by the Employee of any of the provisions of Section 9 of
this Agreement.  The Company may require, as a condition precedent to making any
payments  under this  paragraph to the  Employee,  that the  Employee  execute a
customary release and covenant not to sue in favor of the Company.  Any payments
under this Section 8(c) shall be subject to Section 5(e).

                  (d)  Termination  By Employee.  The Employee may terminate his
employment  hereunder  with or without Good Reason (as defined below) by written
notice to the Company.

500450.4
                                        6

<PAGE>



In the event the  Employee  elects to  terminate  this  Agreement  without  Good
Reason,  then the  Employee  shall offer to continue to provide  services to the
Company in accordance  with this  Agreement for a period of not less than ninety
(90) days from the date that the  Employee  elects to resign.  The  Company  may
accept such offer in full,  accept such offer subject to the Company's  right to
terminate the  Employee's  employment  during such ninety (90) day period (which
termination  shall  nevertheless be treated as a termination by Employee without
Good Reason) or reject such offer in which event the Employee's employment shall
immediately  terminate.  Effective  upon the date of Employee's  termination  of
employment  following  the  Employee's  resignation  without  Good  Reason,  the
Employee  shall be entitled to no further  compensation  or benefits  under this
Agreement.  In the event the Employee  terminates his  employment  hereunder for
Good  Reason,  the  Employee  shall be entitled  to the  benefits  specified  in
Subsection  (c) of this Section 9 as if Employee's  employment was terminated by
the Company  without Cause.  As used in this  Agreement,  the term "Good Reason"
shall mean either the reduction of the Employee's  salary below the Floor Amount
per year  without  the  written  consent of the  Employee  or the failure by the
Company to comply with its  obligations  under this  Agreement  in any  material
respects which failure to comply  continues for a period of not less than thirty
(30) days following written notice thereof by the Employee to the Company.

                  (e)      Change of Control.

                           (i) As used in this  Agreement,  the term  "Change of
Control" shall mean:

                                   (A)  Individuals  who, as of the date of this
Agreement,  constitute  the Board of Directors  of the Company  (the  "Incumbent
Board")  cease for any reason to  constitute  at least a majority of such Board;
provided,  however,  that any individual  becoming a director  subsequent to the
date hereof whose election, or nomination for election by the
500450.4
                                        7

<PAGE>



Company  shareholders,  was  approved  by a vote of at least a  majority  of the
directors then comprising the Incumbent Board shall be considered as though such
individual was a member of the Incumbent Board, but excluding, for this purpose,
any individual whose initial assumption of such directorship  occurs as a result
of either an actual or  threatened  election  contest (as such terms are used in
Section 14a-11 of Regulation 14A promulgated  under the Securities  Exchange Act
of 1934 (the  "Exchange  Act")) or other actual or  threatened  solicitation  of
proxies or consents by or on behalf of an individual, entity or group other than
the Board;

                                   (B) The acquisition by an individual,  entity
or group (within the means of Section  13(d)(3) or 14(d)(2) of the Exchange Act)
other than a trustee or other  fiduciary  holding  securities  under an employee
benefit plan of the Company, of Beneficial Ownership (as defined in that certain
Shareholder  Protection  Rights  Agreement dated as of December 20, 1996 between
the Company and SunTrust Bank, as such agreement may be modified or amended from
time to time) of 15% or more of  either  the then  outstanding  shares of common
stock of the Company or the  combined  voting  power of the  outstanding  voting
securities  of the  Company  entitled  to  vote  generally  in the  election  of
directors  unless the Incumbent  Board  determines  that  transaction  shall not
constitute a "Change of Control" hereunder;

                                   (C)   If   there   occurs   any   merger   or
consolidation of the Company with or into any other corporation or entity (other
than a  wholly-owned  subsidiary  of the  Company)  unless the  Incumbent  Board
determines  that such  transaction  shall not  constitute  a "Change of Control"
hereunder; or

                                   (D) There occurs a sale or disposition by the
Company of all or substantially all of the Company's assets.

500450.4
                                        8

<PAGE>



Notwithstanding  the  foregoing,  no Change of  Control  shall be deemed to have
occurred  for  purposes of this  Agreement  by virtue of any  transaction  which
results in the  Employee,  or a group of persons  which  includes the  Employee,
acquiring  directly  or  indirectly  all or  substantially  of the assets of the
Company.

                           (ii)  In the  event  of any  termination  (including,
without  limitation,  any such  termination  at the  election  of  Employee)  of
Employee's employment with the Company occurring within six (6) months following
the  occurrence  of any event  constituting  a Change of  Control  other  than a
termination  of  employment  occurring  as  a  result  of  a  termination  under
Subsections  (a) or (b) of this  Section  8 (being a  termination  for  death or
disability or a termination by the Company for Cause),  the Company shall pay to
the Employee the sum of the following:

                                   (A) The  Employee's  base salary  through the
date of  termination at the rate in effect just prior to the date of termination
of employment,  plus any benefits or awards  (including  both the cash and stock
component)  which  pursuant  to the terms of any  compensation  plans  have been
earned  or become  payable,  but  which  have not yet been paid to the  Employee
(including  amounts  which  previously  had  been  deferred  at  the  Employee's
request);  (B) A lump sum  payment in cash in an amount  equal to 2.99 times the
Employee's  annual  base  salary  in  effect  immediately  prior  to the date of
termination of employment (but not less than the Floor Amount per year); and (C)
The Company  shall  maintain  in full force and effect,  at the sole cost of the
Company (except for any regular  contributions  of the Employee  required of the
Employee in the same manner as required by all other managerial employees of the
Company),  for the continued  benefit of the Employee and his  dependents  for a
period terminating on the

500450.4
                                        9

<PAGE>



earlier  of (x)  twelve  months  after  such  date  of  termination  or (y)  the
commencement  date of equivalent  benefits from a new employer,  all insured and
self-insured  Employee  group health  insurance  plans in which the Employee was
entitled to participate  immediately prior to the date of termination,  provided
that the Employee's continued  participation is possible under the general terms
and provisions of such plans and that applicable tax requirements do not require
that the value of such  benefits  (not  including  the  premiums) be included in
Employee's income. The terms of this Subsection are in addition to any rights or
obligations arising under applicable law.

                           (iii) In the event any payment or distribution by the
Company  or  acceleration  of any rights to or for the  benefit of the  Employee
(whether paid or payable or distributable  or accelerated  pursuant to the terms
of this Agreement or otherwise (a "Payment"))  will be subject to the excise tax
(collectively, the "Excise Tax") imposed by Section 4999 of the Internal Revenue
Code of 1986, as amended (the "Code"), then the amounts payable under Subsection
(e)(ii) of this Section  shall first be reduced  (prior to reducing the Payments
under any other agreement with or for the benefit of the Employee) to the extent
necessary so that no Payment shall be subject to the Excise Tax,  except that no
such reduction  shall be made to the extent that the Payments  receivable by the
Employee net of all taxes  (including,  without  limitation,  income taxes,  the
Excise  Tax and any  interest  and  penalties  with  respect  to any such  taxes
(collectively,  the "Taxes")) on such Payments  before such  reduction  would be
greater than the Payments receivable by the Employee net of all taxes after such
reduction.  All  determinations  required to be made under this clause  shall be
made by Deloitte & Touche LLP, Atlanta,  Georgia,  or such other accounting firm
as may be  mutually  agreed  to  between  the  Employee  and  the  Company  (the
"Accounting Firm"). For purposes of making such determinations by the Accounting
Firm (A) no portion of any Payment which tax counsel, selected by the Accounting
Firm and acceptable to the Employee, determines not to constitute

500450.4
                                       10

<PAGE>



a "parachute  payment" within the meaning of Section 280G(b)(2) of the Code will
be taken into  account,  (B) no portion of any  payment  which such tax  counsel
determines  to be  reasonable  compensation  for  services  rendered  within the
meaning of Section  280G(b)(4) of the Code will be taken into  account,  (C) the
value of any non-cash benefit or any deferred payment or benefit included in the
Payments will be determined by the Accounting  Firm in accordance  with Sections
280G(d)(3)  and (4) of the Code, and (D) any  reductions  under this  Subsection
shall  be made  serially  against  Subsections  (A),  (B) and (C) of  Subsection
(e)(ii)  of this  Section  and in that  order.  All  fees  and  expenses  of the
Accounting  Firm and any tax counsel  selected  under this  Subsection  shall be
borne solely by the Company,  and any  determination  by the Accounting Firm and
such tax counsel shall be binding upon the Company and the Employee. Any Payment
due under  this  Subsection  (e) shall be paid to the  Employee  by the  Company
within  ten  (10)  days  of  the  Company's  receipt  of the  Accounting  Firm's
determination.

         9.   Protective Covenants; Remedies.

              (a) Property Rights. The Employee acknowledges and agrees that all
records of the accounts of customers,  lists,  prospect lists, prospect reports,
vendor lists,  samples,  notebooks,  computers,  computer  records and software,
policy and procedure  manuals,  price lists,  catalogs,  premises keys,  written
methods  of  pricing,  lists of needs and  requirements  of  customers,  written
methods of  operation  of the Company or any  subsidiary  or  affiliates  of the
Company (collectively, the "Company Group"), manufacturing techniques, financial
records and any other records and books relating in any manner whatsoever to the
customers of the Company Group or its business, whether prepared by the Employee
or otherwise coming into the Employee's  possession,  are the exclusive property
of the Company  Group  regardless  of who  actually  purchased  or prepared  the
original book, record, list or other property. All such books,

500450.4
                                       11

<PAGE>



records,  lists or other property shall be immediately  returned by the Employee
to the Company upon any termination of employment.

              (b)  Non-Disclosure  of  Confidential  Information.  The  Employee
acknowledges  that  through his  employment  by the Company,  the Employee  will
become familiar with, among other things, the following:

                  Any  scientific  or technical  information,  design,  process,
                  procedure, formula or improvement that is secret and of value,
                  and information  including,  but not limited to,  technical or
                  nontechnical data, formula, patterns, compilations,  programs,
                  devices,  methods,  techniques,  drawings and  processes,  and
                  product,  customer and financial data, which the Company takes
                  reasonable efforts to protect from disclosure,  and from which
                  the Company derives actual or potential  economic value due to
                  its  confidential  nature  (the  foregoing  being  hereinafter
                  collectively referred to as the "Confidential Information").

              The  Employee   acknowledges   that  use  or  disclosure  of  such
Confidential  Information  would be  injurious  to the Company and will give the
Employee an unfair  competitive  advantage  over the Company  Group in the event
that  the  Employee  should  go  into   competition   with  the  Company  Group.
Accordingly,  the Employee agrees that during the term of this Agreement and for
a period of two (2) years  subsequent to the  termination  of employment for any
reason,  the  Employee  will not  disclose  to any  person,  or utilize  for the
Employee's  benefit,   any  of  the  Confidential   Information.   The  Employee
acknowledges that such Confidential Information is of special and peculiar value
to the Company;  is the property of the Company  Group,  the product of years of
experience and trial and error;  is not generally  known to the Company  Group's
competitors;  and is  regularly  used in the  operation  of the Company  Group's
business. The Employee acknowledges and recognizes that applicable law prohibits
disclosure of trade secrets  indefinitely (i.e.,  without regard to the two year
period described in

500450.4
                                       12

<PAGE>



this paragraph), and the Company has the right to require the Employee to comply
with such law in addition to the Company's rights under this paragraph.

              (c)  Non-Interference  With Employees.  The Employee agrees not to
solicit,  entice or otherwise  induce any employee of the Company Group to leave
the employ of the Company Group for any reason whatsoever,  and not to otherwise
interfere  with any  contractual  or business  relationship  between the Company
Group and any of its  employees  for two (2) years from the  termination  of the
Employee's employment other than a termination of employment within the scope of
Subsection (e)(ii) of Section 8 of this Agreement.

              (d)  Non-Solicitation  of  Customers.  For so long as the Employee
shall be due or shall have accrued salary payments from the Company  (including,
without limitation any such payment under Subsections (c) or (d) of Section 8 of
this  Agreement  which  Employee  does not waive and  refund to the  Company  in
advance of taking any actions prohibited by this Subsection),  and, in the event
of any termination of Employee's  employment  hereunder by the Company for Cause
or by the Employee without Good Reason,  for one (1) year after the date of such
termination  of  employment,  the Employee  agrees that the  Employee  will not,
within the United States of America (the  "Territory"),  which the parties agree
is the territory from which the Employee shall primarily renders  services,  for
the  Employee's  own  benefit  or on behalf of any  other  person,  partnership,
company or  corporation,  contact any customer or customers of the Company Group
who the Employee  called upon or with which the Employee  became  familiar while
employed by the Company, for the purpose of developing, manufacturing or selling
disposable,  specialty  or safety  products  for use in medical,  industrial  or
commercial markets,  which products and markets are more particularly  described
in the Company's Annual Report on Form 10-K for the year ended December 31, 1996
(collectively, the "Business").

500450.4
                                       13

<PAGE>



This  Subsection  shall  not  apply  following  the date of any  termination  of
employment  within  the  scope  of  Subsection  (e)(ii)  of  Section  8 of  this
Agreement.

              (e)  Non-Competition.  For so long as the Employee shall be due or
shall  have  accrued  salary  payments  from  the  Company  (including,  without
limitation  any  payment  under  Subsections  (c) or (d) of  Section  8 of  this
Agreement  which Employee does not waive and refund to the Company in advance of
taking  any  action  prohibited  by this  Subsection),  and in the  event of any
termination  of Employee's  employment  hereunder by the Company for Cause or by
the  Employee  without  Good  Reason,  for one (1) year  after  the date of such
termination  of employment,  the Employee  agrees that the Employee will not (i)
within the Territory,  either directly or indirectly,  whether on his own behalf
or in the service of others  (whether as an employee,  director,  consultant  or
advisor)  in any  capacity  that  involves  duties  similar to the duties of the
Employee hereunder,  engage in the Business or, (ii) become an owner (except for
the ownership of not greater then an interest of five percent of a publicly held
company) of any company which is engaged in the Business.  This Subsection shall
not apply following the date of any  termination of employment  within the scope
of Subsection (e)(ii) of Section 8 of this Agreement.

              (f) Acknowledgment  Regarding Protective  Covenants.  The Employee
acknowledges  that  the  Employee  has read and  understands  the  terms of this
Agreement,  that the same was specifically  negotiated,  and that the protective
covenants  agreed upon herein are  necessary  for the  protection of the Company
Group's business.  Further, the Employee acknowledges that the Company would not
employ the Employee without the  specifically  negotiated  protective  covenants
herein stated.

              (g) Remedies.  In addition to any other rights and remedies  which
are  available  to the  Company,  with respect to any breach or violation of the
protective covenants set forth

500450.4
                                       14

<PAGE>



herein,  it is recognized  and agreed that the Company shall be entitled to seek
injunctive  relief which would prohibit the Employee from  continuing any breach
or violation of such protective covenants.

         10. Arbitration of Disputes. Any controversy or claim arising out of or
relating to the  employment  relationship  between the Company and the  Employee
shall be settled by  arbitration.  Either  party may  commence  the  arbitration
process by filing a written  demand for  arbitration  with the Atlanta,  Georgia
office of the Judicial Arbitration & Mediation  Service/EnDispute ("JAMS"), with
a copy to the other party. An arbitrator from the panel maintained by JAMS shall
be jointly  selected  by the Company  and the  Employee.  If the Company and the
Employee cannot agree on the  appointment of the arbitrator  within fifteen (15)
days after commencement of the arbitration process, then the arbitrator shall be
appointed by JAMS. Such  arbitration  shall be conducted in the City of Atlanta,
Georgia in accordance  with the rules of JAMS,  except as otherwise  provided in
this  paragraph.  Judgment  upon the award entered by the  arbitrators  shall be
final and may be entered in a court having  jurisdiction  thereof.  The party or
parties  against whom an arbitration  award shall be entered shall pay the other
party's  reasonable  attorneys'  fees  and  reasonable  costs  and  expenses  in
connection with the enforcement of its rights under this Agreement unless and to
the extent the arbitrator  determines that under the  circumstances  recovery by
the prevailing party of all or any part of such fees and costs would be unjust.

         11. No  Conflicting  Agreements.  The Employee  hereby  represents  and
warrants  that  the  execution  of this  Agreement  and the  performance  of his
obligations hereunder will not breach or be in conflict with any other agreement
to which he is a party or by which he is bound,  and that he is not  subject  to
any  covenants  against  competition  or  similar  covenants  which  affect  the
performance of his obligations hereunder.

500450.4
                                       15

<PAGE>



         12. Consulting Cooperation. The Employee shall cooperate fully with the
Company in the  defense  or  prosecution  of any claims or actions  which may be
brought  against  or on  behalf  of  the  Company  which  relate  to  events  or
occurrences that transpired while the Employee was employed by the Company.  The
Employee's  full  cooperation  in  connection  with such claims or actions shall
include,  but not be limited to, being available to meet with counsel to prepare
for  discovery  or trial and to act as a witness  on  behalf of the  Company  at
mutually  convenient  times.  The Employee shall also  cooperate  fully with the
Company in  connection  with any  examination  or review by any federal or state
regulatory  authority  as any such  examination  or review  relates to events or
occurrences that transpired while the Employee was employed by the Company.  The
obligations under this Section shall continue, to the extent required, following
the  expiration  of this  Agreement.  To the extent the  Employee is required to
provide  services  under  this  Section  subsequent  to the  expiration  of this
Agreement,  the  Company  shall  continue  to  reimburse  the  Employee  for the
Employee's  reasonable expenses in connection with the performance of his duties
under this Section and pay a consulting fee in the amount of $200 per hour.

         13.  Notices.  Any notice  required or permitted to be given under this
Agreement shall be in writing and personally  delivered or sent by registered or
certified mail,  return receipt  requested,  in the case of the Company,  to the
principal office of the Company directed to the attention of the Company's Board
of Directors,  and in the case of the  Employee,  to the  Employee's  last known
residence address.

         14.  Construction.  This Agreement shall be governed and interpreted in
accordance with the laws of the State of Georgia. The waiver by any party hereto
of a breach of any of the provisions of this  Agreement  shall not operate or be
construed as a waiver of any subsequent breach by any party.

500450.4
                                       16

<PAGE>



         15. Modification;  Assignment. This Agreement may not be changed except
by  written  agreement  duly  executed  by the  parties  hereto.  The rights and
obligations  of the Company under this  Agreement  shall inure to the benefit of
and be binding upon the successors and assigns of the Company.  This  Agreement,
being for the personal  services of the  Employee,  shall not be  assignable  or
subject to anticipation by the Employee.

         16. Severability.  Each provision of this Agreement shall be considered
severable.  If for any reason any provisions herein are determined to be invalid
or  unenforceable,  this Agreement  shall be construed in all respects as though
such invalid or  unenforceable  provisions were omitted,  and such invalidity or
unenforceability  shall not impair or otherwise affect the validity of the other
provisions  of this  Agreement.  Moreover,  the  parties  agree to replace  such
invalid  provision  with a  substitute  provision  that will  correspond  to the
original intent of the parties.

         17. Number of Agreements.  This Agreement may be executed in any number
of counterparts, each one of which shall be deemed an original.

         18.  Pronouns.  The use of any word in any  gender  shall be  deemed to
include any other gender and the use of any word in the singular shall be deemed
to include the plural where the context requires.

         19.  Headings.  The section  headings  used in this  Agreement  are for
convenience  only and are not to be  controlling  with  respect to the  contents
thereof.

         20.  Entire  Agreement.   This  Agreement  contains  the  complete  and
exclusive statement of the terms and conditions of the Employee's  employment by
the Company,  and there exists no other inducement or consideration  between the
Company  and  the  Employee  relative  to the  employment  contemplated  by this
Agreement. All prior agreements relative to the subject matter of this Agreement
are terminated.

500450.4
                                       17

<PAGE>


         IN WITNESS WHEREOF,  the parties hereto have executed this Agreement to
be effective as of the date first set forth above.

ISOLYSER COMPANY, INC.


By:    ___________________________                ______________________________
                                                  Terence N. Furness
Its:   ___________________________




500450.4
                                       18



                              EMPLOYMENT AGREEMENT

         THIS AGREEMENT  ("Agreement")  is made and entered into effective as of
the 14 day of February,  1998 (the "Effective  Date"),  by and between  ISOLYSER
COMPANY, INC., a Georgia corporation  (hereinafter the "Company"),  and MIGIRDIC
NALBANTYAN (hereinafter the "Employee").

                                    RECITALS:

         R-1.  The  Company  develops,   manufactures  and  markets  disposable,
specialty  and safety  products for use in medical,  industrial  and  commercial
markets.
 
         R-2.     The Company's markets are worldwide.

         R-3.  The Company  maintains  certain  trade  secrets and  confidential
information which is proprietary to the Company,  the disclosure or exploitation
of which would cause significant damage to the Company.

         R-4.  The  Company  desires to employ the  Employee,  and the  Employee
desires to accept such  employment,  for which  purposes each of the Company and
the  Employee  desire to enter  into  this  Agreement  to set forth and  clarify
certain of the terms and conditions relevant to such employment.

         R-5. The Company  recognizes  that,  as is the case with many  publicly
held  corporations,  the  possibility of a Change in Control (as defined herein)
may arise which may create uncertainty and questions among management  resulting
in a departure or  distraction  of management  personnel to the detriment of the
Company and its shareholders.  In addition, the Company believes that should the
Company or its  shareholders  receive a proposal  for transfer of control of the
Company, the Employee should be able to assess and advise the Company

483294.2

<PAGE>



whether  such  proposal  would be in the best  interests  of the Company and its
shareholders  and to take such other action regarding such proposal as the Board
of Directors might determine to be appropriate  without being  influenced by the
uncertainty of the Employee's own situation.

         NOW,  THEREFORE,  in consideration  of the recitals,  the covenants and
agreements  herein  contained  and the  benefits  to be  derived  herefrom,  the
parties, intending to be legally bound, agree as follows:

         1.  Recitals.  The  recitals  set forth above  constitute  part of this
Agreement and are incorporated herein by this reference.

         2.  Employment.  From and after the date hereof and for the term herein
provided,  the Company agrees to employ the Employee,  and the Employee  accepts
such employment  with the Company upon the terms and conditions  hereinafter set
forth.

         3. Term. The Employee's employment shall commence on the Effective Date
and,  subject to Section 8 of this Agreement,  shall continue  through the third
anniversary of the Effective Date.

         4. Duties.  Subject to the  direction and  supervision  of the Board of
Directors of the Company, the Employee agrees that: (a) he shall devote his full
working time and  attention  to the  business of the Company and its  affiliated
companies;  (b) he will  perform all of his duties  pursuant  to this  Agreement
faithfully and to the best of his abilities in a manner  intended to advance the
Company's interests;  and (c) he shall not engage in any other business activity
except:  (i) investing assets in a manner not prohibited by Section 9(e) of this
Agreement, and in such form or manner as shall not require any material services
on his part in the  operations or affairs of the companies or other  entities in
which such  investments  are made, (ii) serving on the board of directors of any
company, subject to the provisions set forth in Section 9(e) of this

483294.2

                                       -2-

<PAGE>



Agreement  and  provided  that he shall not be required  to render any  material
services with respect to the  operations  or affairs of any such company,  (iii)
engaging in religious,  charitable or other  community or non-profit  activities
which do not impair his ability to fulfill his duties and responsibilities under
this Agreement,  or (iv) such other  activities as may be expressly  approved in
advance by the Board of Directors of the Company.

         5. Compensation.  As full compensation for all services rendered by the
Employee  pursuant to this  Agreement and as full  consideration  for all of the
terms of this Agreement,  the Employee shall receive from the Company during his
employment  under this  Agreement the base salary,  bonuses and fringe  benefits
described below.

                  (a) Base Salary.  For all services  rendered  pursuant to this
Agreement,  the Company  shall pay or cause to be paid to the Employee an annual
base salary of $150,000 (the "Floor Amount"). The annual salary may be increased
or (subject to the terms of this  Agreement)  decreased from time to time during
the term of this  Agreement in the  discretion  of the Company.  The base salary
shall be payable in accordance  with the customary  practices of the Company for
payment of its employees,  but in any event, in installments not less frequently
than once monthly.

                  (b) Bonus  Compensation.  To the extent that the Company shall
establish, from time to time in its discretion, bonus compensation plans for the
benefit of all of its management level employees, the Employee shall be entitled
to participate  in such bonus  compensation  plans in accordance  with terms and
provisions established by the Board of Directors in its discretion.

                  (c) Long Term Incentive Payments.  The Company has or may from
time to time in the  future  grant  to the  Employee  such  long-term  incentive
compensation (including, by 

483294.2

                                       -3-

<PAGE>



way of illustration but not limitation, stock options) as the Board of Directors
may determine in its discretion.

                  (d) Fringe Benefits. The Company has adopted, or may from time
to time adopt,  policies in respect of fringe benefits for its management  level
employees  in the  nature  of health  and life  insurance,  holidays,  vacation,
disability and other matters. The Company covenants and agrees that the Employee
shall be entitled to participate in any such fringe benefit  policies adopted by
the Company to the same extent that such fringe  benefits  shall be available to
and for the benefit of all other management level employees.

                  (e) Tax Withholdings and Other  Deductions.  The Company shall
have the right to deduct  from the base salary and any  additional  compensation
payable to the  Employee  all amounts  required to be deducted  and  withheld in
accordance  with social  security  taxes and all applicable  federal,  state and
local  taxes and  charges  as may now be in  effect  or which  may be  hereafter
enacted or required as charges on the compensation of the Employee.  The Company
shall  also have the right to offset  from the base  salary  and any  additional
compensation  payable  to the  Employee  any loan or other  amounts  owed to the
Company by the Employee.

         6. Working Facilities.  The Company, at its own expense,  shall furnish
the Employee with office,  working space and such equipment as may be reasonably
necessary for the Employees's performance of his or her duties.

         7.  Expenses.  The Employee is required as a condition of employment to
incur  ordinary,  necessary  and  reasonable  expenses for the  promotion of the
business of the Company and its affiliates and subsidiaries,  including expenses
for entertaining,  travel and similar items. The Employee is authorized to incur
reasonable  expenses in  connection  with such  business,  including  travel and
entertainment expenses, fees for seminars and courses, and expenses

483294.2

                                       -4-

<PAGE>



incurred in attendance  at executive  meetings and  conventions.  If paid by the
Employee,  upon  presentation  by the  Employee of an  itemized  account of such
expenditures  in a manner  satisfactory  to the Company,  the Employee  shall be
entitled to receive  reimbursement for these expenses,  subject to policies that
may be  established  from time to time by the  Company.  It is  intended  by the
Company and the Employee that all expenses  incurred  pursuant to this paragraph
are to be ordinary and necessary business expenses.

         8.  Termination.   The  Employee's  employment  may  be  terminated  in
accordance  with the provisions of this Section.  The provisions for termination
are as follows:

                  (a) Death or Disability.  The Employee's  employment  shall be
terminated upon the death or total disability of the Employee (total  disability
meaning  the  failure  of  the  Employee  to  perform  his  or  her  duties  and
responsibilities  hereunder  in the manner and to the  extent  required  by this
Agreement  for a period of 180  consecutive  days by  reason  of the  Employee's
mental or physical  disability  as  determined  by the Board of Directors of the
Company, which determination, in the absence of a showing of bad faith, shall be
conclusive upon the Employee).

                  (b)  Termination For Cause.  The Employee's  employment may be
terminated by the Company for Cause.  For purposes of this  Agreement,  the term
"Cause"  shall mean a  determination  by the Board of Directors  that any of the
following has occurred: (i) the Employee's material failure or refusal to comply
with the policies,  standards and  regulations  of the Company from time to time
reasonably  established and fairly administered by the Company,  (ii) a material
breach by the  Employee  of the terms of  Section 9 of this  Agreement,  (iii) a
material  breach by the Employee of any of the other terms of this  Agreement or
any written agreement entered by the parties concurrently  herewith, or (iv) the
indictment or conviction of the Employee for any felony,  the  conviction of the
Employee for a misdemeanor involving the

483294.2

                                       -5-

<PAGE>



misuse of funds,  or the  adjudication  by a court that the Employee  engaged in
willful misconduct in connection with the activities of the Company.

                  (c) Termination  Without Cause. The Employee's  employment may
be terminated by the Company without Cause; provided,  that, in the event of any
termination of the Employee's  employment under this paragraph (c), the Employee
shall be entitled to receive  such  Employee's  annual base salary (but not less
than the Floor  Amount per year) as then in effect as set forth in Section  5(a)
hereof until the first anniversary of the date of such termination of employment
payable at the  Company's  election  either in a lump sum  (present  valued at a
discount rate of 10%) or as otherwise  payable under Section 5(a). The Company's
obligation to make payments  under this  paragraph  shall cease and terminate in
the event of any breach by the Employee of any of the provisions of Section 9 of
this Agreement.  The Company may require, as a condition precedent to making any
payments  under this  paragraph to the  Employee,  that the  Employee  execute a
customary release and covenant not to sue in favor of the Company.  Any payments
under this Section 8(c) shall be subject to Section 5(e).

                  (d)  Termination  By Employee.  The Employee may terminate his
employment  hereunder  with or without Good Reason (as defined below) by written
notice to the  Company.  In the  event the  Employee  elects to  terminate  this
Agreement  without  Good Reason,  then the  Employee  shall offer to continue to
provide  services to the Company in accordance  with this Agreement for a period
of not less than  ninety  (90) days  from the date that the  Employee  elects to
resign.  The Company may accept such offer in full, accept such offer subject to
the Company's  right to terminate the Employee's  employment  during such ninety
(90)  day  period  (which   termination  shall  nevertheless  be  treated  as  a
termination by Employee without Good Reason) or reject such offer in which event
the Employee's employment shall immediately

483294.2

                                       -6-

<PAGE>



terminate.  Effective  upon the date of  Employee's  termination  of  employment
following the Employee's  resignation without Good Reason, the Employee shall be
entitled to no further  compensation  or benefits under this  Agreement.  In the
event the Employee  terminates  his  employment  hereunder for Good Reason,  the
Employee  shall be entitled to the benefits  specified in Subsection (c) of this
Section 9 as if Employee's  employment  was  terminated  by the Company  without
Cause. As used in this  Agreement,  the term "Good Reason" shall mean either the
reduction of the  Employee's  salary below the Floor Amount per year without the
written consent of the Employee or the failure by the Company to comply with its
obligations  under this  Agreement in any  material  respects  which  failure to
comply  continues  for a period of not less  than  thirty  (30)  days  following
written notice thereof by the Employee to the Company.

                  (e) Change of Control.

                           (i) As used in this  Agreement,  the term  "Change of
Control" shall mean:

                                   (A)  Individuals  who, as of the date of this
Agreement,  constitute  the Board of Directors  of the Company  (the  "Incumbent
Board")  cease for any reason to  constitute  at least a majority of such Board;
provided,  however,  that any individual  becoming a director  subsequent to the
date  hereof  whose  election,   or  nomination  for  election  by  the  Company
shareholders,  was  approved by a vote of at least a majority  of the  directors
then  comprising  the  Incumbent  Board  shall  be  considered  as  though  such
individual was a member of the Incumbent Board, but excluding, for this purpose,
any individual whose initial assumption of such directorship  occurs as a result
of either an actual or  threatened  election  contest (as such terms are used in
Section 14a-11 of Regulation 14A promulgated under the Securities Exchange

483294.2

                                       -7-

<PAGE>



Act of 1934 (the "Exchange Act")) or other actual or threatened  solicitation of
proxies or consents by or on behalf of an individual, entity or group other than
the Board;

                                   (B) The acquisition by an individual,  entity
or group (within the means of Section  13(d)(3) or 14(d)(2) of the Exchange Act)
other than a trustee or other  fiduciary  holding  securities  under an employee
benefit plan of the Company, of Beneficial Ownership (as defined in that certain
Shareholder  Protection  Rights  Agreement dated as of December 20, 1996 between
the Company and SunTrust Bank, as such agreement may be modified or amended from
time to time  (the  "Rights  Agreement"))  of 15% or more  of  either  the  then
outstanding  shares of common stock of the Company or the combined  voting power
of the outstanding  voting  securities of the Company entitled to vote generally
in the election of directors  unless the Incumbent  Board  determines  that such
transaction shall not constitute a "Change of Control" hereunder;

                                   (C)   If   there   occurs   any   merger   or
consolidation of the Company with or into any other corporation or entity (other
than a  wholly-owned  subsidiary  of the  Company)  unless the  Incumbent  Board
determines  that such  transaction  shall not  constitute  a "Change of Control"
hereunder; or

                                   (D) There occurs a sale or disposition by the
Company of all or substantially all of the Company's assets.

Notwithstanding  the  foregoing,  no Change of  Control  shall be deemed to have
occurred  for  purposes of this  Agreement  by virtue of any  transaction  which
results in the  Employee,  or a group of persons  which  includes the  Employee,
acquiring  directly  or  indirectly  all or  substantially  of the assets of the
Company.

483294.2

                                       -8-

<PAGE>



                           (ii) In the event of any  termination  of  Employee's
employment  with the  Company  occurring  within  six (6) months  following  the
occurrence  of  any  event  constituting  a  Change  of  Control  other  than  a
termination  of  employment  occurring  as  a  result  of  a  termination  under
Subsections  (a) or (b) of this  Section  8 (being a  termination  for  death or
disability or a termination by the Company for Cause),  the Company shall pay to
the Employee the sum of the following:

                                   (A) The  Employee's  base salary  through the
date of  termination at the rate in effect just prior to the date of termination
of employment,  plus any benefits or awards  (including  both the cash and stock
component)  which  pursuant  to the terms of any  compensation  plans  have been
earned  or become  payable,  but  which  have not yet been paid to the  Employee
(including  amounts  which  previously  had  been  deferred  at  the  Employee's
request);

                                   (B) A lump sum  payment  in cash in an amount
equal to 2.99 times the  Employee's  annual  base  salary in effect  immediately
prior to the date of  termination  of  employment  (but not less  than the Floor
Amount per year); and

                                   (C) If  Employee's  employment  is terminated
within the scope of Subsection  (e)(ii) of this Section,  then the Company shall
maintain in full force and effect,  at the sole cost of the Company  (except for
any regular  contributions of the Employee  required of the Employee in the same
manner as required by all other  managerial  employees of the Company),  for the
continued benefit of the Employee and his dependents for a period terminating on
the  earlier of (x) twelve  months  after  such date of  termination  or (y) the
commencement  date of equivalent  benefits from a new employer,  all insured and
self-insured  Employee  group health  insurance  plans in which the Employee was
entitled to participate

483294.2

                                       -9-

<PAGE>



immediately  prior  to the date of  termination,  provided  that the  Employee's
continued  participation  is possible  under the general terms and provisions of
such plans and that applicable tax requirements do not require that the value of
such benefits be included in Employee's income. The terms of this Subsection are
in addition to any rights or obligations arising under applicable law.

                           (iii) In the event any payment or distribution by the
Company  or  acceleration  of any rights to or for the  benefit of the  Employee
(whether paid or payable or distributable  or accelerated  pursuant to the terms
of this Agreement or otherwise (a "Payment"))  will be subject to the excise tax
imposed by Section  4999 of the Internal  Revenue Code of 1986,  as amended (the
"Code"),  or any interest or penalties are incurred by the Employee with respect
to such excise tax  (collectively,  the "Excise Tax"),  then the amounts payable
under  Subsection  (e)(ii) of this  Section  shall  first be  reduced  (prior to
reducing the Payments  under any other  agreement with or for the benefit of the
Employee)  to the extent  necessary  so that no Payment  shall be subject to the
Excise Tax,  except that no such reduction  shall be made to the extent that the
Payments  receivable  by  the  Employee  net of all  taxes  (including,  without
limitation, income taxes and the Excise Tax (collectively, the "Taxes")) on such
Payments before such reduction would be greater than the Payments  receivable by
the Employee net of all taxes after such reduction.  All determinations required
to be made under this clause  shall be made by  Deloitte & Touche LLP,  Atlanta,
Georgia,  or such other accounting firm as may be mutually agreed to between the
Employee and the Company (the  "Accounting  Firm").  For purposes of making such
determinations  by the  Accounting  Firm (A) no  portion  of any  Payment  which
Employee  has waived in writing  prior to the date of payment will be taken into
account,  (B) no portion  of any  Payment  which tax  counsel,  selected  by the
Accounting Firm and acceptable to

483294.2

                                      -10-

<PAGE>



the  Employee,  determines  not to constitute a "parachute  payment"  within the
meaning of Section  280G(b)(2)  of the Code will be taken into  account,  (C) no
portion  of any  payment  which such tax  counsel  determines  to be  reasonable
compensation for services  rendered within the meaning of Section  280G(b)(4) of
the Code will be taken into  account,  (D) the value of any non-cash  benefit or
any deferred  payment or benefit  included in the Payments will be determined by
the Accounting Firm in accordance with Sections  280G(d)(3) and (4) of the Code,
and (E) any  reductions  under this  Subsection  shall be made serially  against
Subsections  (A), (B) and (C) of Subsection  (e)(ii) of this Section and in that
order. All fees and expenses of the Accounting Firm and any tax counsel selected
under  this  Subsection   shall  be  borne  solely  by  the  Company,   and  any
determination  by the Accounting Firm and such tax counsel shall be binding upon
the Company and the Employee. Any Payment due under this Subsection (e) shall be
paid to the  Employee  by the  Company  within  ten (10)  days of the  Company's
receipt of the Accounting Firm's determination.

         9. Protective Covenants; Remedies.

                  (a) Property Rights. The Employee acknowledges and agrees that
all records of the  accounts  of  customers,  lists,  prospect  lists,  prospect
reports,  vendor  lists,  samples,  desk  calendars,   briefcases,  day  timers,
notebooks,  computers,  computer  records  and  software,  policy and  procedure
manuals, price lists, catalogs, premises keys, written methods of pricing, lists
of needs and  requirements  of  customers,  written  methods of operation of the
Company  or any  subsidiary  or  affiliate  of the  Company  (collectively,  the
"Company  Group"),  manufacturing  techniques,  financial  records and any other
records and books  relating in any manner  whatsoever  to the  customers  of the
Company  Group or its  business,  whether  prepared by the Employee or otherwise
coming into the Employee's possession, are the exclusive property of the Company

483294.2

                                      -11-

<PAGE>



Group  regardless  of who actually  purchased  or prepared  the  original  book,
record, list or other property. All such books, records, lists or other property
shall  be  immediately  returned  by  the  Employee  to  the  Company  upon  any
termination of employment.

                  (b) Non-Disclosure of Confidential  Information.  The Employee
acknowledges  that  through his  employment  by the Company,  the Employee  will
become familiar with, among other things, the following:

                  Any  scientific  or technical  information,  design,  process,
                  procedure, formula or improvement that is secret and of value,
                  and information  including,  but not limited to,  technical or
                  nontechnical data, formula, patterns, compilations,  programs,
                  devices,  methods,  techniques,  drawings and  processes,  and
                  product,  customer and financial data, which the Company takes
                  reasonable efforts to protect from disclosure,  and from which
                  the Company derives actual or potential  economic value due to
                  its  confidential  nature  (the  foregoing  being  hereinafter
                  collectively referred to as the "Confidential Information").

                  The  Employee  acknowledges  that  use or  disclosure  of such
Confidential  Information  would be  injurious  to the Company and will give the
Employee an unfair  competitive  advantage  over the Company  Group in the event
that  the  Employee  should  go  into   competition   with  the  Company  Group.
Accordingly,  the Employee agrees that during the term of this Agreement and for
a period of two (2) years  subsequent to the  termination  of employment for any
reason,  the  Employee  will not  disclose  to any  person,  or utilize  for the
Employee's  benefit,   any  of  the  Confidential   Information.   The  Employee
acknowledges that such Confidential Information is of special and peculiar value
to the Company;  is the property of the Company  Group,  the product of years of
experience and trial and error;  is not generally  known to the Company  Group's
competitors;  and is  regularly  used in the  operation  of the Company  Group's
business. The Employee acknowledges and recognizes that applicable law prohibits

483294.2

                                      -12-

<PAGE>



disclosure of  confidential  information and trade secrets  indefinitely  (i.e.,
without  regard to the two year period  described  in this  paragraph),  and the
Company  has the  right to  require  the  Employee  to  comply  with such law in
addition to the Company's rights under this paragraph.

                  (c) Non-Interference  With Employees.  The Employee agrees not
to solicit,  entice or  otherwise  induce any  employee of the Company  Group to
leave the  employ of the  Company  Group for any reason  whatsoever,  and not to
otherwise  interfere with any contractual or business  relationship  between the
Company Group and any of its employees for two (2) years from the termination of
the  Employee's  employment  other than a termination  of employment  within the
scope of Subsection (e)(ii) of Section 8 of this Agreement.

                  (d) Non-Solicitation of Customers. For so long as the Employee
shall be due or shall have accrued salary payments from the Company  (including,
without limitation any such payment under Subsections (c) or (d) of Section 8 of
this  Agreement  which  Employee  does not waive and  refund to the  Company  in
advance of taking any actions prohibited by this Subsection),  and, in the event
of any termination of Employee's  employment  hereunder by the Company for Cause
or by the Employee without Good Reason,  for one (1) year after the date of such
termination  of  employment,  the Employee  agrees that the  Employee  will not,
within the world (the  "Territory"),  which the parties  agree is the  territory
from which the Employee shall primarily renders services, for the Employee's own
benefit or on behalf of any other person,  partnership,  company or corporation,
contact any customer or customers of the Company  Group who the Employee  called
upon or with which the Employee  became  familiar while employed by the Company,
for the purpose of developing, manufacturing or selling disposable, specialty or
safety   products  for  use  in  medical,   industrial  or  commercial   markets
(collectively, the

483294.2

                                      -13-

<PAGE>



"Business").  This  Subsection  shall  not  apply  following  the  date  of  any
termination of employment within the scope of Subsection (e)(ii) of Section 8 of
this Agreement.

                  (e) Non-Competition.  For so long as the Employee shall be due
or shall have  accrued  salary  payments  from the Company  (including,  without
limitation  any  payment  under  Subsections  (c) or (d) of  Section  8 of  this
Agreement  which Employee does not waive and refund to the Company in advance of
taking  any  action  prohibited  by this  Subsection),  and in the  event of any
termination  of Employee's  employment  hereunder by the Company for Cause or by
the  Employee  without  Good  Reason,  for one (1) year  after  the date of such
termination  of employment,  the Employee  agrees that the Employee will not (i)
within the Territory,  either directly or indirectly,  whether on his own behalf
or in the service of others  (whether as an employee,  director,  consultant  or
advisor)  in any  capacity  that  involves  duties  similar to the duties of the
Employee hereunder,  engage in the Business, or (ii) become an owner (except for
the ownership of not greater than an interest of five percent of a publicly held
company) of any company which is engaged in the Business.  This Subsection shall
not apply following the date of any  termination of employment  within the scope
of Subsection (e)(ii) of Section 8 of this Agreement.

                  (f) Inventions and  Discoveries.  The Employee agrees to fully
inform and disclose to the Company all  inventions,  designs,  improvements  and
discoveries  which the Employee now has or may hereafter  while  employed by the
Company obtain which either  constitutes an improvement to or a modification  of
any of the products which from time to time are under development by the Company
or being manufactured or marketed by the Company (collectively,  the "Products")
or constitute  an  invention,  design,  improvement  or discovery  having unique
application to the Products, whether conceived by the Employee alone or with

483294.2

                                      -14-

<PAGE>



others during or outside the usual hours of work. All such inventions,  designs,
improvements and discoveries shall be the exclusive property of the Company. The
Employee  shall assist the Company to obtain such legal  protection  of all such
inventions,  designs, improvements and discoveries as may be deemed desirable by
the Company from time to time. This  Subsection  shall survive any expiration or
earlier termination of this Agreement.

                  (g)  Acknowledgment   Regarding  Protective   Covenants.   The
Employee  acknowledges  that the Employee has read and  understands the terms of
this  Agreement,  that  the  same  was  specifically  negotiated,  and  that the
protective  covenants agreed upon herein are necessary for the protection of the
Company Group's business.  Further,  the Employee  acknowledges that the Company
would not employ the Employee  without the  specifically  negotiated  protective
covenants herein stated.

                  (h)  Remedies.  In addition to any other  rights and  remedies
which are  available to the Company,  with respect to any breach or violation of
the protective  covenants set forth herein, it is recognized and agreed that the
Company shall be entitled to obtain  injunctive  relief which would prohibit the
Employee from continuing any breach or violation of such protective covenants.

         10.  Disputes.  Any  controversy or claim arising out of or relating to
the  employment  relationship  between  the Company  and the  Employee  shall be
settled by arbitration by three  arbitrators,  one of whom shall be appointed by
the Company, one by the Employee and the third by the first two arbitrators.  If
the first two arbitrators cannot agree on the appointment of a third arbitrator,
then  the  third  arbitrator  shall be  appointed  by the  American  Arbitration
Association in the City of Atlanta, Georgia. Such arbitration shall be conducted
in the City of Atlanta,  Georgia in  accordance  with the rules of the  American
Arbitration Association, except

483294.2

                                      -15-

<PAGE>



as otherwise provided in this paragraph.  Judgment upon the award entered by the
arbitrators  shall be final and may be  entered in a court  having  jurisdiction
thereof. The party or parties against whom an arbitration award shall be entered
shall pay the other party's reasonable  attorneys' fees and reasonable costs and
expenses in connection  with the  enforcement of its rights under this Agreement
unless and to the extent the arbitrators  determine that under the circumstances
recovery by the prevailing party of all or any part of such fees and costs would
be unjust.

         11. No  Conflicting  Agreements.  The Employee  hereby  represents  and
warrants  that  the  execution  of this  Agreement  and the  performance  of his
obligations hereunder will not breach or be in conflict with any other agreement
to which he is a party or by which he is bound,  and that he is not  subject  to
any  covenants  against  competition  or  similar  covenants  which  affect  the
performance of his obligations hereunder.

         12. Consulting Cooperation. The Employee shall cooperate fully with the
Company in the  defense  or  prosecution  of any claims or actions  which may be
brought  against  or on  behalf  of  the  Company  which  relate  to  events  or
occurrences that transpired while the Employee was employed by the Company.  The
Employee's  full  cooperation  in  connection  with such claims or actions shall
include,  but not be limited to, being available to meet with counsel to prepare
for  discovery  or trial and to act as a witness  on  behalf of the  Company  at
mutually  convenient  times.  The Employee shall also  cooperate  fully with the
Company in  connection  with any  examination  or review by any federal or state
regulatory  authority  as any such  examination  or review  relates to events or
occurrences that transpired while the Employee was employed by the Company.  The
obligations under this Section shall continue, to the extent required, following
the  expiration  of this  Agreement.  To the extent the  Employee is required to
provide services

483294.2

                                      -16-

<PAGE>



under this Section  subsequent to the expiration of this Agreement,  the Company
shall continue to reimburse the Employee for the Employee's  reasonable expenses
in connection  with the  performance  of his duties under this Section and pay a
consulting fee in the amount of $50 per hour.

         13.  Notices.  Any notice  required or permitted to be given under this
Agreement shall be in writing and personally  delivered or sent by registered or
certified mail,  return receipt  requested,  in the case of the Company,  to the
principal office of the Company directed to the attention of the Company's Board
of Directors,  and in the case of the  Employee,  to the  Employee's  last known
residence address.

         14.  Construction.  This Agreement shall be governed and interpreted in
accordance with the laws of the State of Georgia. The waiver by any party hereto
of a breach of any of the provisions of this  Agreement  shall not operate or be
construed as a waiver of any subsequent breach by any party.

         15. Modification;  Assignment. This Agreement may not be changed except
by  written  agreement  duly  executed  by the  parties  hereto.  The rights and
obligations  of the Company under this  Agreement  shall inure to the benefit of
and be binding upon the successors and assigns of the Company.  This  Agreement,
being for the personal  services of the  Employee,  shall not be  assignable  or
subject to anticipation by the Employee.

         16. Severability.  Each provision of this Agreement shall be considered
severable.  If for any reason any provisions herein are determined to be invalid
or  unenforceable,  this Agreement  shall be construed in all respects as though
such invalid or  unenforceable  provisions were omitted,  and such invalidity or
unenforceability  shall not impair or otherwise affect the validity of the other
provisions of this Agreement. Moreover, the parties agree to replace such

483294.2

                                      -17-

<PAGE>


invalid  provision  with a  substitute  provision  that will  correspond  to the
original intent of the parties.

         17. Number of Agreements.  This Agreement may be executed in any number
of counterparts, each one of which shall be deemed an original.

         18.  Pronouns.  The use of any word in any  gender  shall be  deemed to
include any other gender and the use of any word in the singular shall be deemed
to include the plural where the context requires.

         19.  Headings.  The section  headings  used in this  Agreement  are for
convenience  only and are not to be  controlling  with  respect to the  contents
thereof.

         20. Entire Agreement.  This Agreement,  together with any other written
agreements  entered  into  concurrently  herewith,  contains  the  complete  and
exclusive statement of the terms and conditions of the Employee's  employment by
the Company,  and there exists no other inducement or consideration  between the
Company  and  the  Employee  relative  to the  employment  contemplated  by this
Agreement. All prior agreements relative to the subject matter of this Agreement
are terminated.

         IN WITNESS WHEREOF,  the parties hereto have executed this Agreement to
be effective as of the date first set forth above.


ISOLYSER COMPANY, INC.


By:
Its:     _____________________________     ____________________________________
                                           MIGIRDIC NALBANTYAN



483294.2

                                      -18-

<PAGE>




<TABLE> <S> <C>


<ARTICLE>                     5
<LEGEND>
     THIS SCHEDULE  CONTAINS SUMMARY  FINANCIAL  INFORMATION  EXTRACTED FROM THE
REGISTRANT'S UNAUDITED FINANCIAL STATEMENTS CONTAINED IN ITS REPORT ON FORM 10-Q
FOR THE  QUARTERLY  PERIOD  ENDED  MARCH 31, 1998 AND IS  QUALIFIED  IN ITS
ENTIRETY BY REFERENCE TO SUCH FINANCIAL STATEMENTS.
</LEGEND>
<CIK>                         0000929299
<NAME>                        ISOLYSER COMPANY, INC.
<MULTIPLIER>                                   1,000
       
<S>                             <C>
<PERIOD-TYPE>                   3-mos
<FISCAL-YEAR-END>                              DEC-31-1998
<PERIOD-START>                                 JAN-01-1998
<PERIOD-END>                                   MAR-31-1998
<CASH>                                               9,813<F1>
<SECURITIES>                                             0
<RECEIVABLES>                                       17,398
<ALLOWANCES>                                         1,968
<INVENTORY>                                         30,091
<CURRENT-ASSETS>                                    92,003
<PP&E>                                              39,115
<DEPRECIATION>                                      18,260
<TOTAL-ASSETS>                                     143,982
<CURRENT-LIABILITIES>                               16,784
<BONDS>                                                  0
                                    0
                                              0
<COMMON>                                                39
<OTHER-SE>                                          85,168
<TOTAL-LIABILITY-AND-EQUITY>                       143,982
<SALES>                                             41,230
<TOTAL-REVENUES>                                    41,230
<CGS>                                               30,588
<TOTAL-COSTS>                                       30,588
<OTHER-EXPENSES>                                    10,998
<LOSS-PROVISION>                                         0
<INTEREST-EXPENSE>                                     950
<INCOME-PRETAX>                                    (1,211)
<INCOME-TAX>                                            76
<INCOME-CONTINUING>                                (1,287)
<DISCONTINUED>                                           0
<EXTRAORDINARY>                                          0
<CHANGES>                                                0
<NET-INCOME>                                       (1,287)
<EPS-PRIMARY>                                       (0.03)
<EPS-DILUTED>                                       (0.03)
<FN>
<F1> INCLUDES CASH EQUIVALENTS.
</FN>
        

</TABLE>


© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission